Loading clinical trials...
Loading clinical trials...
Prescription Pattern and Adverse Events of Postoperative Antithrombotic Regimes for Free Flap Surgery in Head and Neck Cancer
This is a cohort study collecting patients with head and neck cancer who underwent free flap surgery at a single medical center between January 2019 and January 2022.
Patient information are collected from the electronic medical records retrospectively: Head and Neck cancer diagnosis: The International Classification of Diseases, Tenth Revision (ICD-10), which included C00-C14, C31, C32, C73, C75.0, C75.4 and C41.1. The cancer stage, alcohol use, betel nut, and smoking, and baseline comorbidities. Surgical characteristics including flap history, ablation time, reconstruction time, donor sites, recipient sites, neck dissection, flap size, anastomosis, artery types, vein types, intraoperative sealants used, and intravenous calcium channel blocker nicardipine to control hypertension after surgery.
Age
20 - No limit years
Sex
ALL
Healthy Volunteers
No
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan
Start Date
October 19, 2022
Primary Completion Date
September 24, 2023
Completion Date
September 24, 2023
Last Updated
April 18, 2024
540
ACTUAL participants
Free Flap surgery
PROCEDURE
Lead Sponsor
Kaohsiung Medical University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions